Dahl Andrew M. 4

What Happened
Andrew M. Dahl, SVP and Corporate Controller at Edwards Lifesciences (EW), disposed of 176 shares on 2026-02-22 as payment to cover an exercise price or tax liability. The shares were recorded at $79.78 each, for a total value of about $14,041. This was a tax-withholding/settlement action tied to equity acquisition (not an open-market sale).

Key Details

• Transaction date and price: 2026-02-22, 176 shares at $79.78 each (total ≈ $14,041).
• Transaction code: F — payment of exercise price or tax liability (shares withheld/surrendered).
• Shares owned after transaction: Not specified in this Form 4 filing.
• Filing: Form 4 filed 2026-02-23 (reports the 2026-02-22 transaction) — appears timely.
• Remark: Filing notes quarterly acquisitions under the issuer’s Employee Stock Purchase Plan (ESPP); this Form 4 reflects changes in beneficial ownership only.

Context
This was a routine tax-withholding disposal commonly used when employees acquire shares through an ESPP or after exercising options. It reflects a settlement to cover taxes, not a directional open-market sale intended as a portfolio move.